# ACETAMINOPHEN AND IBUPROFEN
> **ANDA218311** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2024-04-26
## Drug
- **FDA Application Number:** ANDA218311
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETAMINOPHEN AND IBUPROFEN
- **Generic name:** ACETAMINOPHEN, IBUPROFEN
- **Active ingredients:** ACETAMINOPHEN; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** GLENMARK THERAPEUTICS INC., USA
- **First approval:** 2024-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218311)
---
*AI Analytics · CC0 1.0*